Skip to main content
Sunshine Lake Pharma Co., Ltd. logo

Sunshine Lake Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 6887 ISIN · CNE1000070M8 HKEX Manufacturing
Open in API
Filings indexed 86 across all filing types
Latest filing 2026-06-03 Regulatory Filings
Country HK Hong Kong
Listing HKEX 6887

About Sunshine Lake Pharma Co., Ltd.

https://www.hecpharm.com

Sunshine Lake Pharma Co., Ltd. is a research-based, vertically integrated pharmaceutical company engaged in the R&D, production, and commercialization of innovative pharmaceutical products. Its core therapeutic focus areas include infectious diseases, chronic diseases, and oncology, with pipeline assets also targeting conditions such as psoriasis and rheumatoid arthritis. The company emphasizes the globalization and accelerated commercialization of its innovative drug portfolio. To enhance its R&D capabilities, Sunshine Lake Pharma utilizes advanced technology platforms, notably through strategic investments in joint ventures focused on AI and robotics for drug discovery. It also participates in the sourcing and supply of pharmaceutical and animal health ingredients.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026
Regulatory Filings Classification · 80% confidence The document is a standardized monthly return (Form FF301) submitted to the Hong Kong Stock Exchange reporting movements in share capital, issued and treasury shares, and public float sufficiency under Listing Rule Chapter 19B. It is a regulatory compliance filing rather than an earnings announcement, annual report, or meeting materials. It does not contain standalone financial statements or qualify as a report publication announcement; it is a routine regulatory submission. Therefore it falls under the 'Regulatory Filings' fallback category (RNS).
2026-06-03 English
CHANGE OF AUTHORISED REPRESENTATIVE AND CHANGE OF BOOK CLOSURE PERIOD AND RECORD DATE
Regulatory Filings Classification · 84% confidence The document is a public announcement to the Hong Kong Stock Exchange of administrative changes – a change of the company’s authorised representative under Rule 3.05 and a revised book closure period/record date for the AGM. It contains no financial statements or management discussion, nor is it a report itself or a presentation; it is an operational regulatory notice. This falls under general regulatory announcements/filings that do not fit a more specific category, so it is classified as RNS.
2026-05-29 English
FORM OF PROXY FOR THE 2025 ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a Form of Proxy for the 2025 Annual General Meeting, which is a solicitation of shareholder votes ahead of the AGM. It is not the AGM presentation itself but rather the proxy material sent to shareholders to request voting instructions. This fits the definition of Proxy Solicitation & Information Statement (PSI).
2026-05-28 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a Notice of Annual General Meeting detailing resolutions to be voted on, instructions for proxy appointment, voting procedures, and meeting logistics. It is a solicitation of shareholder votes rather than the AGM materials (presentations) themselves, and it is not a full annual report or financial statement. Thus, it matches Proxy Solicitation & Information Statement (PSI).
2026-05-28 English
CIRCULAR OF 2025 ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a shareholder circular containing detailed explanatory information on resolutions to be voted at the upcoming Annual General Meeting (AGM), including the notice of AGM, proposals for election of directors, amendments to articles, mandates, remuneration plan, audit re-appointment, and related governance matters. It is a proxy solicitation/information statement sent to shareholders requesting votes, not the actual annual report or a post‐meeting voting result. This matches the definition of a “Proxy Solicitation & Information Statement” (PSI).
2026-05-28 English
PROPOSED RE-ELECTION AND APPOINTMENTS OF DIRECTORS OF THE SECOND SESSION OF THE BOARD
Board/Management Information Classification · 90% confidence The document is an announcement on the Hong Kong Stock Exchange of proposed re-elections and new appointments to the company’s board of directors, including biographical details and shareholdings. It clearly relates to changes in the Board’s composition and senior management. This falls under the Board/Management Information category (MANG).
2026-05-28 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.